Literature DB >> 24390324

Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation.

Valery S Matthys1, Velasco Cimica, Nadine A Dalrymple, Nicole B Glennon, Chris Bianco, Erich R Mackow.   

Abstract

Hantaviruses successfully replicate in primary human endothelial cells by restricting the early induction of beta interferon (IFN-β) and interferon-stimulated genes (ISGs). Gn proteins from NY-1V, ANDV, and TULV, but not PHV, harbor elements in their 142-residue cytoplasmic tails (GnTs) that inhibit RIG-I/MAVS/TBK1-TRAF3-directed IFN-β induction. Here, we define GnT interactions and residues required to inhibit TRAF3-TBK1-directed IFN-β induction and IRF3 phosphorylation. We observed that GnTs bind TRAF3 via residues within the TRAF-N domain (residues 392 to 415) and that binding is independent of the MAVS-interactive TRAF-C domain (residues 415 to 568). We determined that GnT binding to TRAF3 is mediated by C-terminal degrons within NY-1V or ANDV GnTs and that mutations that add degrons to TULV or PHV GnTs confer TRAF3 binding. Further analysis of GnT domains revealed that TRAF3 binding is a discrete GnT function, independent of IFN regulation, and that residues 15 to 42 from the NY-1V GnT C terminus are required for inhibiting TBK1-directed IFN-β transcription. Mutagenesis of the NY-1V GnT revealed that altering tyrosine 627 (Y627A/S/F) abolished GnT regulation of RIG-I/TBK1-directed IRF3 phosphorylation and transcriptional responses of ISRE, κB, and IFN-β promoters. Moreover, GnTs from NY-1V, ANDV, and TULV, but not PHV, inhibited RIG-I-directed IRF3 phosphorylation. Collectively, these findings suggest a novel role for GnTs in regulating RIG-I/TBK1 pathway-directed IRF3 phosphorylation and IFN-β induction and define virulence determinants within GnTs that may permit the attenuation of pathogenic hantaviruses. IMPORTANCE These findings provide a mechanism for selected hantavirus GnT interactions to regulate RIG-I/TBK1 signaling responses required for IFN-β induction by inhibiting TBK1 phosphorylation of IRF3. These studies culminate in showing that a single GnT residue, Y627, is required for the NY-1V GnT to inhibit RIG-I/TBK1-directed IRF3 phosphorylation and IFN-β induction. These findings define a potential virulence determinant within the NY-1V GnT that may permit hantavirus attenuation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390324      PMCID: PMC3911538          DOI: 10.1128/JVI.02647-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses.

Authors:  R Yanagihara; D J Silverman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

Authors:  S D Der; A Zhou; B R Williams; R H Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

Review 3.  Expanding TRAF function: TRAF3 as a tri-faced immune regulator.

Authors:  Hans Häcker; Ping-Hui Tseng; Michael Karin
Journal:  Nat Rev Immunol       Date:  2011-06-10       Impact factor: 53.106

4.  Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein.

Authors:  J Hepojoki; T Strandin; H Wang; O Vapalahti; A Vaheri; H Lankinen
Journal:  J Gen Virol       Date:  2010-05-05       Impact factor: 3.891

5.  Antagonism of type I interferon responses by new world hantaviruses.

Authors:  Jessica R Levine; Joseph Prescott; Kyle S Brown; Sonja M Best; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

Review 6.  Hantaviruses: a global disease problem.

Authors:  C Schmaljohn; B Hjelle
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

7.  beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure.

Authors:  I N Gavrilovskaya; M Shepley; R Shaw; M H Ginsberg; E R Mackow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

8.  Serological survey of Prospect Hill virus infection in indigenous wild rodents in the USA.

Authors:  R Yanagihara; C A Daum; P W Lee; L J Baek; H L Amyx; D C Gajdusek; C J Gibbs
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

9.  OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3.

Authors:  Hongbo Hu; George C Brittain; Jae-Hoon Chang; Nahum Puebla-Osorio; Jin Jin; Anna Zal; Yichuan Xiao; Xuhong Cheng; Mikyoung Chang; Yang-Xin Fu; Tomasz Zal; Chengming Zhu; Shao-Cong Sun
Journal:  Nature       Date:  2013-01-20       Impact factor: 69.504

Review 10.  Regulation of the innate immune system by ubiquitin and ubiquitin-like modifiers.

Authors:  Diede Oudshoorn; Gijs A Versteeg; Marjolein Kikkert
Journal:  Cytokine Growth Factor Rev       Date:  2012-09-08       Impact factor: 7.638

View more
  23 in total

1.  The Andes Orthohantavirus NSs Protein Antagonizes the Type I Interferon Response by Inhibiting MAVS Signaling.

Authors:  Jorge Vera-Otarola; Loretto Solis; Fernando Lowy; Valeria Olguín; Jenniffer Angulo; Karla Pino; Nicole D Tischler; Carola Otth; Paula Padula; Marcelo López-Lastra
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  Hantavirus interferon regulation and virulence determinants.

Authors:  Erich R Mackow; Nadine A Dalrymple; Velasco Cimica; Valery Matthys; Elena Gorbunova; Irina Gavrilovskaya
Journal:  Virus Res       Date:  2014-01-08       Impact factor: 3.303

3.  Andes virus nucleocapsid protein interrupts protein kinase R dimerization to counteract host interference in viral protein synthesis.

Authors:  Zekun Wang; Mohammad A Mir
Journal:  J Virol       Date:  2014-11-19       Impact factor: 5.103

4.  Effects of Different Doses of Nucleocapsid Protein from Hantaan Virus A9 Strain on Regulation of Interferon Signaling.

Authors:  Wen Pan; Gang Bian; Kezhen Wang; Tingting Feng; Jianfeng Dai
Journal:  Viral Immunol       Date:  2015-07-21       Impact factor: 2.257

Review 5.  Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?

Authors:  Alison M Kell
Journal:  J Mol Biol       Date:  2021-09-04       Impact factor: 5.469

Review 6.  Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.

Authors:  Solène Lerolle; Natalia Freitas; François-Loïc Cosset; Vincent Legros
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

Review 7.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

8.  Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant.

Authors:  Nadine A Dalrymple; Velasco Cimica; Erich R Mackow
Journal:  MBio       Date:  2015-05-12       Impact factor: 7.867

9.  TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea.

Authors:  Ga Bin Park; Dae Young Hur; Yeong Seok Kim; Hyun-Kyung Lee; Jae Wook Yang; Daejin Kim
Journal:  J Cell Mol Med       Date:  2015-03-06       Impact factor: 5.310

Review 10.  Hantavirus immunology of rodent reservoirs: current status and future directions.

Authors:  Tony Schountz; Joseph Prescott
Journal:  Viruses       Date:  2014-03-14       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.